Axsome Therapeutics, Inc.
US ˙ NasdaqGM ˙ US05464T1043

SecurityAXSM / Axsome Therapeutics, Inc.
InsiderMark Coleman
This page shows the track record and history of Coleman Mark insider trades in Axsome Therapeutics, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Mark Coleman in AXSM / Axsome Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
2025-09-08 800 127.2000 800 127.2000 101,760 0 129.2900 1,672 1.64
2025-09-08 287 127.3000 287 127.3000 36,535
2025-09-08 488 127.4000 488 127.4000 62,171
2021-11-18 409 35.0700 409 35.0700 14,344
2021-11-18 1,021 35.1000 1,021 35.1000 35,837
2021-05-12 500 58.1500 500 58.1500 29,075
2020-06-29 650 78.5000 650 78.5000 51,025
2019-06-26 15,800 23.1000 15,800 23.1000 364,980
2019-06-25 400 23.2500 400 23.2500 9,300
2019-05-13 4,650 21.4400 4,650 21.4400 99,696
2019-03-19 5,100 12.1800 5,100 12.1800 62,118

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

AXSM / Axsome Therapeutics, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Mark Coleman in AXSM / Axsome Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
2025-05-20 3,000 107.4910 3,000 107.4910 322,473 69 100.3900 -21,303 -6.61

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

AXSM / Axsome Therapeutics, Inc. Insider Trades
Insider Transaction History
File
Date		 Trade
Date		 Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price		 Unit
Price		 Units
Changed		 Value
Changed (1K)		 Remaining
Options		 Remaining
Shares
2025-09-09 2025-09-08 4 Coleman Mark AXSM Common Stock P - Purchase D 127.4000 488 62 48,212
2025-09-09 2025-09-08 4 Coleman Mark AXSM Common Stock P - Purchase D 127.3000 287 37 47,724
2025-09-09 2025-09-08 4 Coleman Mark AXSM Common Stock P - Purchase D 127.2000 800 102 47,437
2025-05-29 2025-05-28 4 Coleman Mark AXSM Common Stock S - Sale D 103.4300 -3,750 -388 46,637
2025-05-29 2025-05-27 4 Coleman Mark AXSM Common Stock S - Sale D 105.4700 -3,750 -396 50,387
2025-05-20 2025-05-20 4 Coleman Mark AXSM Common Stock S - Sale D 107.4910 -3,000 -322 54,137
2025-01-06 2025-01-03 4 Coleman Mark AXSM Common Stock M - Exercise D 9.0000 9,127 82 57,137
2024-11-20 2024-11-19 4 Coleman Mark AXSM Common Stock M - Exercise D 5.9400 33,410 198 48,010
2024-05-29 2024-05-29 4 Coleman Mark AXSM Common Stock S - Sale D 75.1396 -5,248 -394 14,600
2024-05-29 2024-05-28 4 Coleman Mark AXSM Common Stock S - Sale D 75.2095 -5,249 -395 19,848
2023-09-15 2023-09-15 4 Coleman Mark AXSM Common Stock S - Sale I 75.1771 -18,572 -1,396 403,856
2023-09-15 2023-09-15 4 Coleman Mark AXSM Common Stock S - Sale D 75.1853 -11,016 -828 25,097
2023-09-15 2023-09-15 4 Coleman Mark AXSM Common Stock M - Exercise D 3.6700 11,016 40 36,113
2023-01-04 2023-01-03 4 Coleman Mark AXSM Common Stock M - Exercise D 1.3000 17,501 23 25,097
2022-03-17 2022-03-15 4 Coleman Mark AXSM Stock Option (Right to Buy) M - Exercise D 1.30 -3,496 17,501
2022-03-17 2022-03-15 4 Coleman Mark AXSM Common Stock M - Exercise D 1.3000 3,496 5 7,596
2022-03-08 2022-03-04 4 Coleman Mark AXSM Stock Option (Right to Buy) A - Award D 29.91 2,798 2,798
2021-11-22 2021-11-18 4 Coleman Mark AXSM Common Stock P - Purchase I 35.1000 1,021 36 422,428
2021-11-22 2021-11-18 4 Coleman Mark AXSM Common Stock P - Purchase I 35.0700 409 14 421,407
2021-06-08 2021-06-04 4 Coleman Mark AXSM Stock Option (Right to Buy) A - Award D 61.32 7,325 7,325
2021-05-13 2021-05-12 4 Coleman Mark AXSM Common Stock P - Purchase I 58.1500 500 29 420,998
2021-03-09 2021-03-05 4 Coleman Mark AXSM Stock Option (Right to Buy) A - Award D 65.02 1,201 1,201
2020-08-20 2020-08-19 4 Coleman Mark By Whale Island, LP AXSM Common Stock G - Gift I 397,998 397,998
2020-08-20 2020-08-19 4 Coleman Mark AXSM Common Stock G - Gift D -397,998 5,700
2020-06-30 2020-06-29 4 Coleman Mark AXSM Common Stock P - Purchase D 78.5000 650 51 403,698
2020-06-05 2020-06-05 4 Coleman Mark AXSM Stock Option (Right to Buy) A - Award D 77.38 13,000 13,000
2020-03-19 2020-03-17 4 Coleman Mark AXSM Stock Option (Right to Buy) A - Award D 45.14 3,308 3,308
2019-06-27 2019-06-26 4 Coleman Mark AXSM Common Stock P - Purchase D 23.1000 15,800 365 668,848
2019-06-27 2019-06-25 4 Coleman Mark AXSM Common Stock P - Purchase D 23.2500 400 9 653,048
2019-06-10 2019-06-07 4 Coleman Mark AXSM Stock Option (Right to Buy) A - Award D 22.03 13,000 13,000
2019-05-15 2019-05-13 4 Coleman Mark AXSM Common Stock P - Purchase D 21.4400 4,650 100 652,648
2019-03-21 2019-03-19 4 Coleman Mark AXSM Common Stock P - Purchase I 12.1800 5,100 62 5,100
2019-03-21 2019-03-19 4 Coleman Mark AXSM Stock Option (Right to Buy) A - Award D 12.95 25,652 25,652
2018-06-05 2018-06-01 4 Coleman Mark AXSM Stock Options (right to buy) A - Award D 3.45 13,000 13,000
2018-04-05 2018-03-12 4 Coleman Mark AXSM Stock Option (Right to Buy) A - Award D 2.85 27,297 27,297
2017-03-17 2017-03-15 4 Coleman Mark AXSM Stock Option (Right to Buy) A - Award D 4.95 11,000 11,000
2017-03-17 2017-03-15 4 Coleman Mark AXSM Stock Option (Right to Buy) A - Award D 4.95 26,456 26,456
2016-06-01 2016-05-27 4 Coleman Mark AXSM Stock Option (Right to Buy) A - Award D 8.02 5,193 5,193
2015-11-24 2015-11-24 4 Coleman Mark AXSM 8% Convertible Note A - Award D 5.94 140,672 0
2015-11-24 2015-11-24 4 Coleman Mark AXSM 8% Convertible Note A - Award D 5.94 180,526 0
2015-11-24 2015-11-24 4 Coleman Mark AXSM 8% Convertible Note A - Award D 5.40 243,750 0
2015-11-24 2015-11-24 4 Coleman Mark AXSM Common Stock C - Conversion D 5.9400 140,672 836 647,998
2015-11-24 2015-11-24 4 Coleman Mark AXSM Common Stock C - Conversion D 5.9400 180,526 1,072 507,326
2015-11-24 2015-11-24 4 Coleman Mark AXSM Common Stock C - Conversion D 5.4000 243,750 1,316 326,800
2015-11-23 2015-11-19 4 Coleman Mark AXSM Employee Stock Option (Right to Buy) A - Award D 9.00 9,127 9,127
2015-11-19 3 Coleman Mark AXSM Common Stock D 166,100
2015-11-19 3 Coleman Mark AXSM Common Stock D 166,100
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)